Angela Dziedzic - Search Results

Year	Number of Results
2017	4
2018	2
2019	4
2020	4
2021	6
2022	4
2023	1

1

[The inflammatory processes in atherogenesis].

Cichoń N, Lach D, Dziedzic A, Bijak M, Saluk J. Cichoń N, et al. Among authors: dziedzic a. Pol Merkur Lekarski. 2017 Mar 21;42(249):125-128. Pol Merkur Lekarski. 2017. PMID: 28333905 Review. Polish.

2

[Inflammatory processes in the pathogenesis of acute coronary syndromes].

Lach D, Cichon N, Dziedzic A, Bijak M, Saluk J. Lach D, et al. Among authors: dziedzic a. Pol Merkur Lekarski. 2017 May 23;42(251):183-186. Pol Merkur Lekarski. 2017. PMID: 28557963 Review. Polish.

3

Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis.

Saluk-Bijak J, Dziedzic A, Bijak M. Saluk-Bijak J, et al. Among authors: dziedzic a. Cells. 2019 Feb 1;8(2):110. doi: 10.3390/cells8020110. Cells. 2019. PMID: 30717273 Free PMC article. Review.

4

Metformin as a Potential Agent in the Treatment of Multiple Sclerosis.

Dziedzic A, Saluk-Bijak J, Miller E, Bijak M. Dziedzic A, et al. Int J Mol Sci. 2020 Aug 19;21(17):5957. doi: 10.3390/ijms21175957. Int J Mol Sci. 2020. PMID: 32825027 Free PMC article. Review.

5

Interactions between platelets and leukocytes in pathogenesis of multiple sclerosis.

Dziedzic A, Bijak M. Dziedzic A, et al. Adv Clin Exp Med. 2019 Feb;28(2):277-285. doi: 10.17219/acem/83588. Adv Clin Exp Med. 2019. PMID: 30411550 Free article. Review.

6

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis.

Dziedzic A, Saluk-Bijak J, Miller E, Niemcewicz M, Bijak M. Dziedzic A, et al. Int J Mol Sci. 2021 Feb 11;22(4):1804. doi: 10.3390/ijms22041804. Int J Mol Sci. 2021. PMID: 33670394 Free PMC article. Review.

7

miR-155 as an Important Regulator of Multiple Sclerosis Pathogenesis. A Review.

Maciak K, Dziedzic A, Miller E, Saluk-Bijak J. Maciak K, et al. Among authors: dziedzic a. Int J Mol Sci. 2021 Apr 21;22(9):4332. doi: 10.3390/ijms22094332. Int J Mol Sci. 2021. PMID: 33919306 Free PMC article. Review.

8

Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment.

Dziedzic A, Saluk J. Dziedzic A, et al. Int J Mol Sci. 2022 Nov 21;23(22):14478. doi: 10.3390/ijms232214478. Int J Mol Sci. 2022. PMID: 36430954 Free PMC article. Review.

9

Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic's Disease) and Multiple Sclerosis-A Review.

Maciak K, Pietrasik S, Dziedzic A, Redlicka J, Saluk-Bijak J, Bijak M, Włodarczyk T, Miller E. Maciak K, et al. Among authors: dziedzic a. Int J Mol Sci. 2021 Aug 20;22(16):8946. doi: 10.3390/ijms22168946. Int J Mol Sci. 2021. PMID: 34445668 Free PMC article. Review.

10

Circulating miRNAs as Potential Biomarkers Distinguishing Relapsing-Remitting from Secondary Progressive Multiple Sclerosis. A Review.

Pietrasik S, Dziedzic A, Miller E, Starosta M, Saluk-Bijak J. Pietrasik S, et al. Among authors: dziedzic a. Int J Mol Sci. 2021 Nov 2;22(21):11887. doi: 10.3390/ijms222111887. Int J Mol Sci. 2021. PMID: 34769314 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results